FOLH1 and posterior cortical atrophy: The Australian PRIMARY trial evaluated the use of PSMA-PET/CT alongside mpMRI in biopsy-naïve men with suspicion of PCa undergoing subsequent biopsy and found a sensitivity of 97% for the detection of clinically significant PCa [3].